Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease

Ethan Moore; Max V. Wohlauer; James Dorosh; Mahmood Kabeil; Rafael D. Malgor; Leigh A. O’Banion; Gabriel Lopez-Pena; Riley Gillette; Kathryn Colborn; Robert F. Cuff; Leah Lucero; Amna Ali; Issam Koleilat; Paola Batarseh; Sonia Talathi; Aksim Rivera; Misty D. Humphries; Kevin Ly; Nikolai Harroun; Brigitte K. Smith; Anna M. Darelli-Anderson; Asad Choudhry; Eric Hammond; Michael Costanza; Vipul Khetarpaul; Ashley Cosentino; Jacob Watson; Rana Afifi; Nicolas J. Mouawad; Tze Woei Tan; Mel Sharafuddin; Judith P. Quevedo; Reggie Nkansah; Palcah Shibale; Sherene Shalhub; Judith C. Lin

doi:10.1177/17085381241240679

Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease

Ethan Moore, Max V. Wohlauer, James Dorosh, Mahmood Kabeil, Rafael D. Malgor, Leigh A. O’Banion, Gabriel Lopez-Pena, Riley Gillette, Kathryn Colborn, Robert F. Cuff, Leah Lucero, Amna Ali, Issam Koleilat, Paola Batarseh, Sonia Talathi, Aksim Rivera, Misty D. Humphries, Kevin Ly, Nikolai Harroun, Brigitte K. SmithAnna M. Darelli-Anderson, Asad Choudhry, Eric Hammond, Michael Costanza, Vipul Khetarpaul, Ashley Cosentino, Jacob Watson, Rana Afifi, Nicolas J. Mouawad, Tze Woei Tan, Mel Sharafuddin, Judith P. Quevedo, Reggie Nkansah, Palcah Shibale, Sherene Shalhub, Judith C. Lin

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: The COVID-19 pandemic has drastically altered the medical landscape. Various strategies have been employed to preserve hospital beds, personal protective equipment, and other resources to accommodate the surges of COVID-19 positive patients, hospital overcapacities, and staffing shortages. This has had a dramatic effect on vascular surgical practice. The objective of this study is to analyze the impact of the COVID-19 pandemic on surgical delays and adverse outcomes for patients with chronic venous disease scheduled to undergo elective operations. Methods: The Vascular Surgery COVID-19 Collaborative (VASCC) was founded in March 2020 to evaluate the outcomes of patients with vascular disease whose operations were delayed. Modules were developed by vascular surgeon working groups and tested before implementation. A data analysis of outcomes of patients with chronic venous disease whose surgeries were postponed during the COVID-19 pandemic from March 2020 through February 2021 was performed for this study. Results: A total of 150 patients from 12 institutions in the United States were included in the study. Indications for venous intervention were: 85.3% varicose veins, 10.7% varicose veins with venous ulceration, and 4.0% lipodermatosclerosis. One hundred two surgeries had successfully been completed at the time of data entry. The average length of the delay was 91 days, with a median of 78 days. Delays for venous ulceration procedures ranged from 38 to 208 days. No patients required an emergent intervention due to their venous disease, and no patients experienced major adverse events following their delayed surgeries. Conclusions: Interventions may be safely delayed for patients with venous disease requiring elective surgical intervention during the COVID-19 pandemic. This finding supports the American College of Surgeons’ recommendations for the management of elective vascular surgical procedures. Office-based labs may be safe locations for continued treatment when resources are limited. Although the interventions can be safely postponed, the negative impact on quality of life warrants further investigation.

Original language	English (US)
Journal	Vascular
DOIs	https://doi.org/10.1177/17085381241240679
State	Accepted/In press - 2024
Externally published	Yes

Keywords

COVID-19
delayed
office based laboratory
surgery
venous

ASJC Scopus subject areas

Surgery
Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1177/17085381241240679

Cite this

Moore, E., Wohlauer, M. V., Dorosh, J., Kabeil, M., Malgor, R. D., O’Banion, L. A., Lopez-Pena, G., Gillette, R., Colborn, K., Cuff, R. F., Lucero, L., Ali, A., Koleilat, I., Batarseh, P., Talathi, S., Rivera, A., Humphries, M. D., Ly, K., Harroun, N., ... Lin, J. C. (Accepted/In press). Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease. Vascular. https://doi.org/10.1177/17085381241240679

Moore, E, Wohlauer, MV, Dorosh, J, Kabeil, M, Malgor, RD, O’Banion, LA, Lopez-Pena, G, Gillette, R, Colborn, K, Cuff, RF, Lucero, L, Ali, A, Koleilat, I, Batarseh, P, Talathi, S, Rivera, A, Humphries, MD, Ly, K, Harroun, N, Smith, BK, Darelli-Anderson, AM, Choudhry, A, Hammond, E, Costanza, M, Khetarpaul, V, Cosentino, A, Watson, J, Afifi, R, Mouawad, NJ, Tan, TW, Sharafuddin, M, Quevedo, JP, Nkansah, R, Shibale, P, Shalhub, S & Lin, JC 2024, 'Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease', Vascular. https://doi.org/10.1177/17085381241240679

@article{47d74dfc6ef743248737501ac117a945,

title = "Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease",

abstract = "Objective: The COVID-19 pandemic has drastically altered the medical landscape. Various strategies have been employed to preserve hospital beds, personal protective equipment, and other resources to accommodate the surges of COVID-19 positive patients, hospital overcapacities, and staffing shortages. This has had a dramatic effect on vascular surgical practice. The objective of this study is to analyze the impact of the COVID-19 pandemic on surgical delays and adverse outcomes for patients with chronic venous disease scheduled to undergo elective operations. Methods: The Vascular Surgery COVID-19 Collaborative (VASCC) was founded in March 2020 to evaluate the outcomes of patients with vascular disease whose operations were delayed. Modules were developed by vascular surgeon working groups and tested before implementation. A data analysis of outcomes of patients with chronic venous disease whose surgeries were postponed during the COVID-19 pandemic from March 2020 through February 2021 was performed for this study. Results: A total of 150 patients from 12 institutions in the United States were included in the study. Indications for venous intervention were: 85.3% varicose veins, 10.7% varicose veins with venous ulceration, and 4.0% lipodermatosclerosis. One hundred two surgeries had successfully been completed at the time of data entry. The average length of the delay was 91 days, with a median of 78 days. Delays for venous ulceration procedures ranged from 38 to 208 days. No patients required an emergent intervention due to their venous disease, and no patients experienced major adverse events following their delayed surgeries. Conclusions: Interventions may be safely delayed for patients with venous disease requiring elective surgical intervention during the COVID-19 pandemic. This finding supports the American College of Surgeons{\textquoteright} recommendations for the management of elective vascular surgical procedures. Office-based labs may be safe locations for continued treatment when resources are limited. Although the interventions can be safely postponed, the negative impact on quality of life warrants further investigation.",

keywords = "COVID-19, delayed, office based laboratory, surgery, venous",

author = "Ethan Moore and Wohlauer, {Max V.} and James Dorosh and Mahmood Kabeil and Malgor, {Rafael D.} and O{\textquoteright}Banion, {Leigh A.} and Gabriel Lopez-Pena and Riley Gillette and Kathryn Colborn and Cuff, {Robert F.} and Leah Lucero and Amna Ali and Issam Koleilat and Paola Batarseh and Sonia Talathi and Aksim Rivera and Humphries, {Misty D.} and Kevin Ly and Nikolai Harroun and Smith, {Brigitte K.} and Darelli-Anderson, {Anna M.} and Asad Choudhry and Eric Hammond and Michael Costanza and Vipul Khetarpaul and Ashley Cosentino and Jacob Watson and Rana Afifi and Mouawad, {Nicolas J.} and Tan, {Tze Woei} and Mel Sharafuddin and Quevedo, {Judith P.} and Reggie Nkansah and Palcah Shibale and Sherene Shalhub and Lin, {Judith C.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

doi = "10.1177/17085381241240679",

language = "English (US)",

journal = "Vascular",

issn = "1708-5381",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease

AU - Moore, Ethan

AU - Wohlauer, Max V.

AU - Dorosh, James

AU - Kabeil, Mahmood

AU - Malgor, Rafael D.

AU - O’Banion, Leigh A.

AU - Lopez-Pena, Gabriel

AU - Gillette, Riley

AU - Colborn, Kathryn

AU - Cuff, Robert F.

AU - Lucero, Leah

AU - Ali, Amna

AU - Koleilat, Issam

AU - Batarseh, Paola

AU - Talathi, Sonia

AU - Rivera, Aksim

AU - Humphries, Misty D.

AU - Ly, Kevin

AU - Harroun, Nikolai

AU - Smith, Brigitte K.

AU - Darelli-Anderson, Anna M.

AU - Choudhry, Asad

AU - Hammond, Eric

AU - Costanza, Michael

AU - Khetarpaul, Vipul

AU - Cosentino, Ashley

AU - Watson, Jacob

AU - Afifi, Rana

AU - Mouawad, Nicolas J.

AU - Tan, Tze Woei

AU - Sharafuddin, Mel

AU - Quevedo, Judith P.

AU - Nkansah, Reggie

AU - Shibale, Palcah

AU - Shalhub, Sherene

AU - Lin, Judith C.

PY - 2024

Y1 - 2024

N2 - Objective: The COVID-19 pandemic has drastically altered the medical landscape. Various strategies have been employed to preserve hospital beds, personal protective equipment, and other resources to accommodate the surges of COVID-19 positive patients, hospital overcapacities, and staffing shortages. This has had a dramatic effect on vascular surgical practice. The objective of this study is to analyze the impact of the COVID-19 pandemic on surgical delays and adverse outcomes for patients with chronic venous disease scheduled to undergo elective operations. Methods: The Vascular Surgery COVID-19 Collaborative (VASCC) was founded in March 2020 to evaluate the outcomes of patients with vascular disease whose operations were delayed. Modules were developed by vascular surgeon working groups and tested before implementation. A data analysis of outcomes of patients with chronic venous disease whose surgeries were postponed during the COVID-19 pandemic from March 2020 through February 2021 was performed for this study. Results: A total of 150 patients from 12 institutions in the United States were included in the study. Indications for venous intervention were: 85.3% varicose veins, 10.7% varicose veins with venous ulceration, and 4.0% lipodermatosclerosis. One hundred two surgeries had successfully been completed at the time of data entry. The average length of the delay was 91 days, with a median of 78 days. Delays for venous ulceration procedures ranged from 38 to 208 days. No patients required an emergent intervention due to their venous disease, and no patients experienced major adverse events following their delayed surgeries. Conclusions: Interventions may be safely delayed for patients with venous disease requiring elective surgical intervention during the COVID-19 pandemic. This finding supports the American College of Surgeons’ recommendations for the management of elective vascular surgical procedures. Office-based labs may be safe locations for continued treatment when resources are limited. Although the interventions can be safely postponed, the negative impact on quality of life warrants further investigation.

AB - Objective: The COVID-19 pandemic has drastically altered the medical landscape. Various strategies have been employed to preserve hospital beds, personal protective equipment, and other resources to accommodate the surges of COVID-19 positive patients, hospital overcapacities, and staffing shortages. This has had a dramatic effect on vascular surgical practice. The objective of this study is to analyze the impact of the COVID-19 pandemic on surgical delays and adverse outcomes for patients with chronic venous disease scheduled to undergo elective operations. Methods: The Vascular Surgery COVID-19 Collaborative (VASCC) was founded in March 2020 to evaluate the outcomes of patients with vascular disease whose operations were delayed. Modules were developed by vascular surgeon working groups and tested before implementation. A data analysis of outcomes of patients with chronic venous disease whose surgeries were postponed during the COVID-19 pandemic from March 2020 through February 2021 was performed for this study. Results: A total of 150 patients from 12 institutions in the United States were included in the study. Indications for venous intervention were: 85.3% varicose veins, 10.7% varicose veins with venous ulceration, and 4.0% lipodermatosclerosis. One hundred two surgeries had successfully been completed at the time of data entry. The average length of the delay was 91 days, with a median of 78 days. Delays for venous ulceration procedures ranged from 38 to 208 days. No patients required an emergent intervention due to their venous disease, and no patients experienced major adverse events following their delayed surgeries. Conclusions: Interventions may be safely delayed for patients with venous disease requiring elective surgical intervention during the COVID-19 pandemic. This finding supports the American College of Surgeons’ recommendations for the management of elective vascular surgical procedures. Office-based labs may be safe locations for continued treatment when resources are limited. Although the interventions can be safely postponed, the negative impact on quality of life warrants further investigation.

KW - COVID-19

KW - delayed

KW - office based laboratory

KW - surgery

KW - venous

UR - http://www.scopus.com/inward/record.url?scp=85188357065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85188357065&partnerID=8YFLogxK

U2 - 10.1177/17085381241240679

DO - 10.1177/17085381241240679

M3 - Article

AN - SCOPUS:85188357065

SN - 1708-5381

JO - Vascular

JF - Vascular

ER -

Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this